Designing novel building blocks is an overlooked strategy to improve compound quality
Year: 2014
Type: review
Source: Drug Discovery Today
Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2140010870
